Mark Mintz, MD
Neurology with Special Qualifications in Child Neurology Physician in Voorhees, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,803 in Neurology with Special Qualifications in Child Neurology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Mark Mintz, MD filed 593 Medicare Part D claims in 2023 as a Neurology with Special Qualifications in Child Neurology Physician in Voorhees, New Jersey, prescribing 92% generic.
- 593
- Part D claims, 2023
- 92%
- generic prescribing
- $440.27
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Mark Mintz, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
593 Top 34% higher than 66% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
Mark Mintz, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Mintz, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in New Jersey
How Neurology with Special Qualifications in Child Neurology Physician compares to other specialties among New Jersey providers
Neurology with Special Qualifications in Child Neurology Physician ranks #161 among New Jersey's specialties (0% of in-state providers)
Each bar is a specialty's share of the New Jersey provider total, by primary NUCC taxonomy. The highlighted bar is Neurology with Special Qualifications in Child Neurology Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Neurology with Special Qualifications in Child Neurology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Mark Mintz, MD appears in the CMS NPPES registry as a Neurology with Special Qualifications in Child Neurology Physician provider holding MD credentials at 1001 LAUREL OAK RD, Voorhees, NJ, 08043, with a listed phone of (856) 346-0005. NPI 1649258450 was issued on 01/03/2006.
Medicare Part D records for calendar year 2023 show 593 prescription claims written by this provider, covering 17 Medicare beneficiaries and totaling roughly $127K in drug spend, split 8% brand-name and 92% generic by claim count.
Neurology with Special Qualifications in Child Neurology Physician is a narrow specialty nationwide, with 1,803 enrolled providers across 51 states and an average of 359 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1649258450 |
|---|---|
| Specialty | Neurology with Special Qualifications in Child Neurology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 01/03/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Mark Mintz, MD's current license status, disciplinary history, and board certifications with the New Jersey State Board of Medical Examiners in New Jersey before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1649258450 is the unique 10-digit identifier CMS uses to link Mintz across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Mintz, MD. Source: openpaymentsdata.cms.gov.
Total received
$440
Largest payer
BioMarin Pharmaceutical Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
8% brand-name claims vs 92% generic, on 593 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 674
- Total Day Supply
- 18,779
- Brand vs Generic
- 8% brand / 92% generic
- Brand Drug Cost
- $77K
- Generic Drug Cost
- $49K
Patient Demographics
- Average Patient Age
- 34.5 years
- Avg HCC Risk Score
- 0.81
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mark Mintz, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Lacosamide
Lacosamide
49 claims
- Oxcarbazepine
Oxcarbazepine
45 claims
- Clorazepate Dipota…
Clorazepate Dipotassium
39 claims
- Divalproex Sodium
Divalproex Sodium
36 claims
- Paliperidone Er
Paliperidone Er
31 claims
- Levetiracetam
Levetiracetam
30 claims
- Hydroxyzine Pamoate
Hydroxyzine Pamoate
26 claims
- Lithium Carbonate Er
Lithium Carbonate Er
23 claims
| Drug | Claims |
|---|---|
| Lacosamide | 49 |
| Oxcarbazepine | 45 |
| Clorazepate Dipotassium | 39 |
| Divalproex Sodium | 36 |
| Paliperidone Er Paliperidone | 31 |
| Levetiracetam | 30 |
| Hydroxyzine Pamoate | 26 |
| Lithium Carbonate Er Lithium Carbonate | 23 |
| Aripiprazole | 21 |
| Lorazepam | 19 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Neurology with Special Qualifications in Child Neurology Physician Overview
How Mark Mintz, MD fits within the Neurology with Special Qualifications in Child Neurology Physician landscape nationally.
Mark Mintz, MD's 593 claims are above the specialty average of 359.
Nearby Neurology with Special Qualifications in Child Neurology Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Mintz.
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New Jersey medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Neurology with Special Qualifications in Child Neurology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Jersey
Frequently Asked Questions
What is Mark Mintz, MD's specialty? ▼
How much does Mark Mintz, MD prescribe under Medicare Part D? ▼
Where is Mark Mintz, MD located? ▼
What is Mark Mintz, MD's NPI number? ▼
Does Mark Mintz, MD prescribe more brand-name or generic drugs? ▼
How many Neurology with Special Qualifications in Child Neurology Physician providers are there in the US? ▼
What drugs does Mark Mintz, MD prescribe most often? ▼
Does Mark Mintz, MD accept Medicare? ▼
How can I verify Mark Mintz, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology